First National Bank of Omaha’s Teladoc Health TDOC Stock Holding History

First National Bank of Omaha’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,006	Closed	-$201K	–	383
2020 Q4	$201K	Buy	+1,006	New	+$205K	0.01%	372

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

First National Bank of Omaha's TDOC Position: Q1 2021 in Review

First National Bank of Omaha sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,006 shares — an estimated $201K sold.

First National Bank of Omaha first reported a position in TDOC in Q4 2020 and held it in 1 quarter. The position peaked at $201K in Q4 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

First National Bank of Omaha reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
First National Bank of Omaha sold 1,006 Teladoc Health shares in Q1 2021, an estimated $201K.
First National Bank of Omaha first reported a position in Teladoc Health in Q4 2020 and held it in 1 quarter.
First National Bank of Omaha's Teladoc Health position peaked at $201K in Q4 2020.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on First National Bank of Omaha's 13F filing for Q1 2021, filed 6 May 2021.